Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia, have developed a device that can isolate individual cancer cells from patient blood samples.
The microfluidic device works by separating the various cell types found in blood by their size. The device may one day enable rapid, cheap liquid biopsies to help detect cancer and develop targeted treatment plans. The findings are reported in the journal Microsystems & Nanoengineering.
“This new microfluidics chip lets us separate cancer cells from whole blood or minimally-diluted blood,” said Ian Papautsky, the Richard and Loan Hill Professor of Bioengineering in the UIC College of Engineering and corresponding author on the paper. “While devices for detecting cancer cells circulating in the blood are becoming available, most are relatively expensive and are out of reach of many research labs or hospitals. Our device is cheap, and doesn’t require much specimen preparation or dilution, making it fast and easy to use.”
The ability to successfully isolate cancer cells is a crucial step in enabling liquid biopsy where cancer could be detected through a simple blood draw. This would eliminate the discomfort and cost of tissue biopsies which use needles or surgical procedures as part of cancer diagnosis. Liquid biopsy could also be useful in tracking the efficacy of chemotherapy over the course of time, and for detecting cancer in organs difficult to access through traditional biopsy techniques, including the brain and lungs.
However, isolating circulating tumor cells from the blood is no easy task, since they are present in extremely small quantities. For many cancers, circulating cells are present at levels close to one per 1 billion blood cells. “A 7.5-milliliter tube of blood, which is a typical volume for a blood draw, might have ten cancer cells and 35-40 billion blood cells,” said Papautsky. “So we are really looking for a needle in a haystack.”
Microfluidic technologies present an alternative to traditional methods of cell detection in fluids. These devices either use markers to capture targeted cells as they float by, or they take advantage of the physical properties of targeted cells — mainly size — to separate them from other cells present in fluids.
Papautsky and his colleagues developed a device that uses size to separate tumor cells from blood. “Using size differences to separate cell types within a fluid is much easier than affinity separation which uses ‘sticky’ tags that capture the right cell type as it goes by,” said Papautsky. “Affinity separation also requires a lot of advanced purification work which size separation techniques don’t need.”
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- Mother, 31, is diagnosed with cervical cancer after putting off a smear test for 10 yearson February 24, 2020 at 8:49 am
Kim Montgomery, 31, claims being pregnant four times 'back-to-back' led to her postponing her cervical screening.
- Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Canceron February 24, 2020 at 6:44 am
Wilcoxon matched-pairs signed rank test was used to test mRNA expression differences between matched prostate cancer samples and adjacent normal prostate tissues from ... However, informed consent for ...
- Phil Murphy has kidney tumor likely to be cancer. Here’s what patients face with that diagnosis.on February 23, 2020 at 4:03 am
Q: What are the warning signs of kidney cancer? A: Symptoms may not be evident early on and patients often find it undergoing an ultrasound or another diagnostic test for an unrelated reason. (This ...
- UCLA gymnast Mercedez Sanchez finds inspiration in her brother’s cancer fighton February 22, 2020 at 9:09 am
The long-awaited blood work confirmed the worst: acute myeloid leukemia ... Confusion of what to do next. Then hope: One of the tests revealed that the cancer hadn’t spread to Liam’s spine or brain ...
- Europe In-vitro Colorectal Cancer Screening Tests Market to Undertake Strapping Growth at 5.0% CAGR to 2026on February 21, 2020 at 5:30 am
According to the Graphical Research new growth forecast report titled "Europe In-vitro Colorectal Cancer Screening Tests Market Share By Test Type (Fecal Occult Blood Tests [Guaiac FOB Stool, ...
- Urine test detects bladder cancer up to 10 years before clinical signson February 20, 2020 at 4:21 pm
A bio-specimen bank of blood, urine, hair and nail samples was created at the beginning of the ... However, this is an extraordinarily promising, simple, and inexpensive test for bladder cancer that, ...
- Doctors at OHSU working on blood test for early cancer detectionon February 20, 2020 at 8:27 am
PORTLAND, OR (KPTV) — Imagine a blood test that could detect cancer early enough to treat it effectively. That’s exactly what doctors at Oregon Health Science University are working on right now.
- New blood test developed in Atlanta could detect ovarian cancer earlieron February 19, 2020 at 9:49 am
ATLANTA — Cutting edge research is underway in Atlanta that could prevent deaths from ovarian cancer. A new blood test that's awaiting approval from the FDA could detect the deadly cancer in it's ...
- Can this early cancer-detection test save lives? A new study aims to find out.on February 19, 2020 at 3:38 am
Grail aims its early cancer-detection test toward an important question: Will results change the course of cancers? #bayarea #biotech ...
- Grail kicks off its first study to provide doctors with real-world results from its multi-cancer blood teston February 18, 2020 at 8:15 am
After gathering tens of thousands of people to participate in its clinical research studies, Grail says it’s got at least one more to do—an interventional trial of its multi-cancer blood test, where ...
via Bing News